Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna E Poterala

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA Oncology|June 23, 2022
Starting a Career in Oncology: Fighting Cancer and Gender DisparitiesJohanna E Poterala, Narjust Duma
Cancer|February 25, 2022
Abbreviated endocrine therapy duration for low estrogen receptor-positive breast cancer: The counter to extended endocrine therapyJohanna E Poterala, Kari B Wisinski
Clinical Breast Cancer|June 8, 2022
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment StrategiesJohanna E Poterala, Thomas Havighurst, Kari Braun Wisinski
Cancers|March 10, 2022
Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast CancerShelby A Fertal, Johanna E Poterala, Suzanne M Ponik, et al.
Journal of the American College of Radiology : JACR|July 9, 2023
Mammography Screening Outreach Through Non-Primary Care-Based ServicesJohanna E Poterala, Edward Stanley, Anand K Narayan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA Oncology|June 23, 2022
Starting a Career in Oncology: Fighting Cancer and Gender DisparitiesJohanna E Poterala, Narjust Duma
Cancer|February 25, 2022
Abbreviated endocrine therapy duration for low estrogen receptor-positive breast cancer: The counter to extended endocrine therapyJohanna E Poterala, Kari B Wisinski
Clinical Breast Cancer|June 8, 2022
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment StrategiesJohanna E Poterala, Thomas Havighurst, Kari Braun Wisinski
Cancers|March 10, 2022
Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast CancerShelby A Fertal, Johanna E Poterala, Suzanne M Ponik, et al.
Journal of the American College of Radiology : JACR|July 9, 2023
Mammography Screening Outreach Through Non-Primary Care-Based ServicesJohanna E Poterala, Edward Stanley, Anand K Narayan, et al.
Pageof 1